In animal studies, a novel pocket on GCKR has been identified, which can induce GCK protein translocation, resulting in glucose‐lowering effects and thus suggesting GCKR as a potential therapeutic target for GDM [8]. This evidence concerns the gene GCKR and gestational diabetes.